Skip to main content

Advertisement

Log in

Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder associated with increased risk for thrombosis and reduced life expectancy. Retinal vein occlusion (RVO) is a frequent cause of vision loss but its relationship with PNH has not been studied systematically. Patients followed up for RVO in our ophthalmology department were screened for the presence of a PNH clone in peripheral blood by means of flow cytometry. The presence of other well-documented risk factors for RVO was also analyzed. In a series of 110 patients (54 males, median age of 67) we found no evidence of PNH. Most patients (97/110) had cardiovascular risk factors and/or hyperhomocysteinemia (67/110). Inherited thrombophilias were rare (three confirmed cases). Therefore, PNH does not appear to play a role in the development of RVO. However, this finding does not necessarily apply to young patients and/or those with no conventional risk factors for RVO, due to the low number of patients in these subgroups in our population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brodsky RA (2014) Paroxysmal nocturnal hemoglobinuria. Blood 124:2804–2811. doi:10.1182/blood-2014-02-522128

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703–711

    Article  CAS  PubMed  Google Scholar 

  3. Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, Brodsky RA, Bessler M, Kanakura Y, Rosse W, Khursigara G, Bedrosian C, Hillmen P (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99:922–929. doi:10.3324/haematol.2013.093161

    Article  PubMed  PubMed Central  Google Scholar 

  4. de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Socié G, French Society of Hematology (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112:3099–3106. doi:10.1182/blood-2008-01-133918

    Article  PubMed  Google Scholar 

  5. Preis M, Lowrey CH (2014) Laboratory tests for paroxysmal nocturnal hemoglobinuria. Am J Hematol 89:339–341. doi:10.1002/ajh.23612

    Article  CAS  PubMed  Google Scholar 

  6. Martí-Carvajal AJ, Anand V, Cardona AF, Solà I (2014) Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database Syst Rev 10:CD010340. doi:10.1002/14651858.CD010340

    Google Scholar 

  7. Jaulim A, Ahmed B, Khanam T, Chatziralli IP (2013) Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina 33:901–910. doi:10.1097/IAE.0b013e3182870c15

    Article  PubMed  Google Scholar 

  8. Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98:133–141

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33:111–131. doi:10.1080/02713680701851902

    Article  PubMed  PubMed Central  Google Scholar 

  10. Stem MS, Talwar N, Comer GM, Stein JD (2013) A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 120:362–370. doi:10.1016/j.ophtha.2012.07.080

    Article  PubMed  Google Scholar 

  11. Newman-Casey PA, Stem M, Talwar N, Musch DC, Besirli CG, Stein JD (2014) Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan. Ophthalmology 121:1939–1948. doi:10.1016/j.ophtha.2014.04.045

    Article  PubMed  PubMed Central  Google Scholar 

  12. Minniti G, Calevo MG, Giannattasio A, Camicione P, Armani U, Lorini R, Piana G (2014) Plasma homocysteine in patients with retinal vein occlusion. Eur J Ophthalmol 24:735–743. doi:10.5301/ejo.5000426

    Article  PubMed  Google Scholar 

  13. Kolar P. (2014) Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. doi:10.1155/2014/724780

    PubMed  PubMed Central  Google Scholar 

  14. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ (2005) Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 93:1021–1026. doi:10.1160/TH04-11-0768

    CAS  PubMed  Google Scholar 

  15. Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M (2007) Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 5:642–645. doi:10.1111/j.1538-7836.2007.02379.x

    Article  CAS  PubMed  Google Scholar 

  16. Sutherland DR, Kuek N, Davidson J, Barth D, Chang H, Yeo E, Bamford S, Chin-Yee I, Keeney M (2007) Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B 72:167–177. doi:10.1002/cyto.b.20151

    Article  Google Scholar 

  17. Cugati S, Wang JJ, Rochtchina E, Mitchell P (2006) Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 124:726–732. doi:10.1001/archopht.124.5.726

    Article  PubMed  Google Scholar 

  18. Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Martinuzzo ME, Cerrato GS, Forastiero RR (2002) Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 13:623–626

    Article  CAS  PubMed  Google Scholar 

  19. Schockman S, Glueck CJ, Hutchins RK, Patel J, Shah P, Wang P (2015) Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clin Ophthalmol 9:591–600. doi:10.2147/OPTH.S80714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Napal JJ, Neila S, Pérez-Montes R, Sierra I, Ruiz S, Hernández JL (2016) The role of coagulation disorders in patients with retinal vein occlusion. QJM 109:97–102. doi:10.1093/qjmed/hcv088

    Article  CAS  PubMed  Google Scholar 

  21. Kirkegaard K, Heegaard S, Hvas AM (2017) No evidence for thrombophilia in patients with retinal venous occlusion: a systematic GRADE-based review. Acta Ophthalmol 95:12–19. doi:10.1111/aos.13214

    Article  PubMed  Google Scholar 

  22. Glueck CJ, Hutchins RK, Jurantee J, Khan Z, Wang P (2012) Thrombophilia and retinal vascular occlusion. Clin Ophthalmol 6:1377–1384. doi:10.2147/OPTH.S34627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Scheuerle AF, Serbecic N, Beutelspacher SC (2009) Paroxysmal nocturnal hemoglobinuria may cause retinal vascular occlusions. Int Ophthalmol 29:187–190. doi:10.1007/s10792-007-9188-9

    Article  PubMed  Google Scholar 

  24. Ageno W, Dentali F, De Stefano V, Barco S, Lerede T, Bazzan M, Piana A, Santoro R, Duce R, Poli D, Martinelli I, Siragusa S, Barillari G, Cattaneo M, Vidili G, Carpenedo M, Rancan E, Giaretta I, Tosetto A (2014) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. Thromb Res 133:1052–1055. doi:10.1016/j.thromres.2014.03.044

    Article  CAS  PubMed  Google Scholar 

  25. Donadini MP, Dentali F, Ageno W (2012) Splanchnic vein thrombosis: new risk factors and management. Thromb Res 129(Suppl 1):S93–S96. doi:10.1016/S0049-3848(12)70025-7

    Article  CAS  PubMed  Google Scholar 

  26. Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J (2010) The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol 45:171–175. doi:10.3129/i09-273

    Article  PubMed  Google Scholar 

  27. Yau JW, Lee P, Wong TY, Best J, Jenkins A (2008) Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J 38:904–910. doi:10.1111/j.1445-5994.2008.01720.x

    Article  CAS  PubMed  Google Scholar 

  28. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 96:5209–5214. doi:10.1182/blood-2004-04-1472

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Hu R, Mukhina GL, Piantadosi S, Barber JP, Jones RJ, Brodsky RA (2005) PIG-A mutations in normal hematopoiesis. Blood 105:3848–3854

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc Sorigue.

Ethics declarations

Conflict of interest

Alexion Barcelona provided FLAER.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sorigue, M., Juncà, J., Orna, E. et al. Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria. J Thromb Thrombolysis 44, 63–66 (2017). https://doi.org/10.1007/s11239-017-1502-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-017-1502-4

Keywords

Navigation